Since TSA and 5-aza-dC treatment were shown to alter IL-13Rα2 expression in prostate cancer cells grown in 2D culture, we investigated whether the treatments could also alter the expression of IL-13Rα2 in prostate cells grown in 3D culture as cell spheroids. Here, IL13RA2 is linked to prostate cancer.